The Singular Health Group Ltd (ASX: SHG) share price took flight today, increasing by 27.2% to 51.5 cents a share. However, the recently listed medical imaging technology company had no news out today.
Singular Health has gained a spot on plenty of watchlists over the last couple of weeks. It might be worth recapping what all the fuss is about.
What does Singular Health offer?
The proprietary technology developed by Singular Health enables the viewing of a 3D image, which is compiled of 2D medical images. More specifically, this technology is the company’s volumetric rendering platform.
Singular Health notes that this technology provides immersive viewing across a range of medical applications. Such applications include orthodontics, maxilla-facial surgery, oncology, general surgery, and orthopedics.
In addition to this, MedVR is Singular Health’s product which allows the viewing of scans through an interactive virtual reality experience.
The company derives its revenue from both initial hardware sales and subscription payments on an on-going basis for the use of software, commonly referred to a software-as-a-service (SaaS).
Recent Singular Health developments affecting the share price
With Singular Health being a small and upcoming player in a fairly competitive space, shareholders would be looking for progress. On Monday, shareholders got exactly that. The company announced that it had received a purchase order totalling $170,000 for development of GeoVR software.
The order was received from FlowCentric Technologies, with which Singular Health is also in the process of finalising a joint venture. The purchase order will enable FlowCentric to conduct a pilot program using Singular Health’s GeoVR software.
You might be thinking, well this a world away from medical imaging. And you’d be correct. But the volumetric rendering technology developed by Singular Health spans multiple use cases. In this instance, it will be used to develop a commercially viable product that utilises imaging and predictive technologies for mining and exploration.
FlowCentric currently services over 350,000 users with its business process management software. These include a number of global resource companies.
For further progress on the medical imaging front, shareholders will have to wait a little longer to see that play out.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
More reading
- Why the Singular Health (ASX:SHG) share price is shooting 10% higher
- The Singular Health (ASX:SHG) share price is now up 140% since its IPO
- Singular Health (ASX:SHG) share price rockets 100% higher following IPO
- Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher
- Singular Health (ASX:SHG) shares arrive on the ASX
Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post The Singular Health (ASX:SHG) share price launched 27% higher today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/37Hje7s
Leave a Reply